# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-036833
Filing Date
2013-05-03
Accepted
2013-05-03 08:51:31
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | a13-8304_110q.htm | 10-Q | 793317
2 | EX-10.1 | a13-8304_1ex10d1.htm | EX-10.1 | 432885
3 | EX-31.1 | a13-8304_1ex31d1.htm | EX-31.1 | 12549
4 | EX-31.2 | a13-8304_1ex31d2.htm | EX-31.2 | 13162
5 | EX-32.1 | a13-8304_1ex32d1.htm | EX-32.1 | 8476
| Complete submission text file | 0001104659-13-036833.txt |  | 6736510

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL INSTANCE DOCUMENT | cldx-20130331.xml | EX-101.INS | 687820
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cldx-20130331.xsd | EX-101.SCH | 75001
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | cldx-20130331_cal.xml | EX-101.CAL | 70976
9 | XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT | cldx-20130331_lab.xml | EX-101.LAB | 1197290
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cldx-20130331_pre.xml | EX-101.PRE | 536610
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | cldx-20130331_def.xml | EX-101.DEF | 323741

Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 13810430
SIC: 2835 In Vitro & In Vivo Diagnostic Substances